US-based healthtech startup gets funding from Magna Investment

Milu Labs, a US-based medical diagnostics company with a presence in Singapore, announced the completion of its first institutional financing. The undisclosed investment was led by South Korean healthcare venture capital fund Magna Investment.

The startup builds, studies, and markets cutting-edge technologies to screen and detect major health conditions. It plans to use the fresh funding for the clinical development of its technology in China and other Asian countries.

Milu leverages artificial intelligence, exosomes, and other sophisticated platforms as it aims to become “Asia’s leading diagnostics and analysis company.”